McDonnell, T., Cussen, L., McIlroy, M
Through the analysis of numerous in vivo and in vitro studies aimed at determining the mechanisms by which GLP-1 enhances insulin secretion in individuals with normal glucose tolerance or T2DM, two main intracellular mechanisms underlying the incretin effect have emerged
The $125/month membership makes care simple and accessible for patients throughout Alaska and includes: Ongoing care with a licensed medical provider Up to one appointment per month , delivered via telehealth or in person when applicable Management of established conditions , medication follow-ups, and routine care Care coordination and documentation support as needed Secure messaging and follow-up communication related to your care plan Please note: The membership is not available for new patients New patient visits, extended visits, procedures, and certain services may require separate scheduling or fees Membership does not guarantee insurance coverage for medications, labs, or imaging Controlled substances, specialty services, and higher-acuity care may require additional evaluation or visits Up to one evaluation or follow-up visit per month (telehealth or in-person) Progress tracking and medication adjustments Messaging access for brief questions between visits Please note: The membership does not include the cost of lab work or medications
As your dose changes through the titration schedule, the optimal concentration may change with it
